Our Team
Our team has taken 25+ drugs into the clinic & been involved in 10+ FDA drug approvals
CO-FOUNDERS
Warren D. Marcus, PhD (CEO)
Over 20 years of drug development experience as a scientist, along with 10+ years of business development experience. Co-inventor of Anktiva (FDA approved 4/22/24)
Involved in deals totaling over $1.2B, including the largest Biotech acquisition in Florida (Altor BioScience acquisition for $1.08B).
Paolo Serafini, PhD (Tech Inventor)
Professor of Microbiology, Immunology, and Otolaryngology at the University of Miami and a member of the Tumor Biology Research Program at the NCI-designated Sylvester Comprehensive Cancer Center (Sylvester).
Leads a research program focused on understanding the interaction between the immune system and the tumor, restoring self-tolerance in autoimmunity, and developing non-viral nanoparticles that allow the in vivo targeted delivery of therapeutics.
Clark Golestani
Advisor
Cuong Do
Advisor
Jay Skyler, MD
Diabetes Expert
Keith McGahan, JD
Legal Consultant
Rocky Washington
Advisor
Emily Noonan Place
Toxicology Consultant
Mark Tracy, PhD
RNA Manufacturing Consultant
Keith Levy
Finance Consultant
